Basic Information
| RNALocate ID: | RLID:01001981 |
| RNA Symbol: | hsa-miR-106b-5p |
| Localization: | Nucleolus |
RNA Information
| RNA Name: | hsa-miR-106b |
| RNA ID: | miRBase:MIMAT0000680 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001977 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001978 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001979 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001980 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001982 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11002321 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002322 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002323 | Exosome | Breast milk | 22211110 |
| RLID:11002324 | Exosome | Brain tissue | 23382797 |
| RLID:11002325 | Exosome | Plasma | 23663360 |
| RLID:11002326 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002327 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11002328 | Exosome | Serum | 25349172 |
| RLID:11002329 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002330 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000107 | Exosome | Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000394 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-106b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-03625 |
| MNDR | hsa-miR-106b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-03626 |
| MNDR | hsa-miR-106b-5p | Oral squamous cell carcinoma | MNDR-E-MI-03627 |
| MNDR | hsa-miR-106b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-03628 |
| MNDR | hsa-miR-106b-5p | Medulloblastoma | MNDR-E-MI-03629 |
| MNDR | hsa-miR-106b-5p | B cell lymphoma of malt type | MNDR-E-MI-03630 |
| MNDR | hsa-miR-106b-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-03631 |
| MNDR | hsa-miR-106b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-03632 |
| MNDR | hsa-miR-106b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-03633 |
| MNDR | hsa-miR-106b-5p | Lymphoma | MNDR-E-MI-03634 |
| MNDR | hsa-miR-106b-5p | Lymphoma non-hodgkin | MNDR-E-MI-03635 |
| MNDR | hsa-miR-106b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-03636 |
| MNDR | hsa-miR-106b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-03637 |
| MNDR | hsa-miR-106b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-03638 |
| MNDR | hsa-miR-106b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-03639 |
| MNDR | hsa-miR-106b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-03640 |
| MNDR | hsa-miR-106b-5p | Acute promyelocytic leukemia | MNDR-E-MI-03641 |
| MNDR | hsa-miR-106b-5p | Breast cancer luminal | MNDR-E-MI-03642 |
| MNDR | hsa-miR-106b-5p | Niemann-pick disease type c | MNDR-E-MI-03643 |
| MNDR | hsa-miR-106b-5p | Prostate cancer | MNDR-E-MI-03644 |
| MNDR | hsa-miR-106b-5p | Chronic lymphocytic leukemia | MNDR-E-MI-03645 |
| MNDR | hsa-miR-106b-5p | Gastric cancer | MNDR-E-MI-03646 |
| MNDR | hsa-miR-106b-5p | Gastric lymphoma | MNDR-E-MI-03647 |
| MNDR | hsa-miR-106b-5p | Alzheimer disease | MNDR-E-MI-03648 |
| MNDR | hsa-miR-106b-5p | Attention deficit hyperactivity disorder | MNDR-E-MI-03649 |
| MNDR | hsa-miR-106b-5p | Intracranial aneurysm | MNDR-E-MI-03650 |
| MNDR | hsa-miR-106b-5p | Bladder cancer | MNDR-E-MI-03651 |
| MNDR | hsa-miR-106b-5p | Esophageal carcinoma | MNDR-E-MI-03652 |
| MNDR | hsa-miR-106b-5p | Dysautonomia familial | MNDR-E-MI-03653 |
| MNDR | hsa-miR-106b-5p | Seizures | MNDR-E-MI-03654 |
| MNDR | hsa-miR-106b-5p | Head and neck cancer | MNDR-E-MI-03655 |
| MNDR | hsa-miR-106b-5p | Leukemia | MNDR-E-MI-03656 |
| MNDR | hsa-miR-106b-5p | Leiomyoma | MNDR-E-MI-03657 |
| MNDR | hsa-miR-106b-5p | Huntington disease | MNDR-E-MI-03658 |
| MNDR | hsa-miR-106b-5p | Chorea | MNDR-E-MI-03659 |
| MNDR | hsa-miR-106b-5p | Cardiovascular disease | MNDR-E-MI-03660 |
| MNDR | hsa-miR-106b-5p | Moyamoya disease | MNDR-E-MI-03661 |
| MNDR | hsa-miR-106b-5p | Lung cancer | MNDR-E-MI-03662 |
| MNDR | hsa-miR-106b-5p | Fragile x syndrome | MNDR-E-MI-03663 |
| MNDR | hsa-miR-106b-5p | Parkinson disease | MNDR-E-MI-03664 |
| MNDR | hsa-miR-106b-5p | Niemann-pick disease | MNDR-E-MI-03665 |
| MNDR | hsa-miR-106b-5p | Basal-like breast cancer | MNDR-E-MI-03666 |
| MNDR | hsa-miR-106b-5p | Pituitary neoplasms | MNDR-E-MI-03667 |
| MNDR | hsa-miR-106b-5p | Pancreatic cancer | MNDR-E-MI-03668 |
| MNDR | hsa-miR-106b-5p | Melanoma | MNDR-E-MI-03669 |
| MNDR | hsa-miR-106b-5p | Lesch-nyhan syndrome | MNDR-E-MI-03670 |
| MNDR | hsa-miR-106b-5p | Rectum adenocarcinoma | MNDR-E-MI-03671 |
| MNDR | hsa-miR-106b-5p | Nephroblastoma | MNDR-E-MI-03672 |
| MNDR | hsa-miR-106b-5p | Colon cancer | MNDR-E-MI-03673 |
| MNDR | hsa-miR-106b-5p | Colon adenocarcinoma | MNDR-E-MI-03674 |
| MNDR | hsa-miR-106b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-03675 |
| MNDR | hsa-miR-106b-5p | Familial ovarian cancer | MNDR-E-MI-03676 |
| MNDR | hsa-miR-106b-5p | Prostate adenocarcinoma | MNDR-E-MI-03677 |
| MNDR | hsa-miR-106b-5p | Laryngeal carcinoma | MNDR-E-MI-03678 |
| MNDR | hsa-miR-106b-5p | Kidney cancer | MNDR-E-MI-03679 |
| MNDR | hsa-miR-106b-5p | Carcinoma ductal breast | MNDR-E-MI-03680 |
| MNDR | hsa-miR-106b-5p | Invasive ductal carcinoma | MNDR-E-MI-03681 |
| MNDR | hsa-miR-106b-5p | Glioblastoma | MNDR-E-MI-03682 |
| MNDR | hsa-miR-106b-5p | Astrocytoma | MNDR-E-MI-03683 |
| MNDR | hsa-miR-106b-5p | Glioma | MNDR-E-MI-03684 |
| MNDR | hsa-miR-106b-5p | Chordoma | MNDR-E-MI-03685 |
| MNDR | hsa-miR-106b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-03686 |
| MNDR | hsa-miR-106b-5p | Temporal lobe epilepsy | MNDR-E-MI-03687 |
| MNDR | hsa-miR-106b-5p | Osteosarcoma | MNDR-E-MI-03688 |
| MNDR | hsa-miR-106b-5p | Liposarcoma | MNDR-E-MI-03689 |
| MNDR | hsa-miR-106b-5p | Coronary artery disease | MNDR-E-MI-03690 |
| MNDR | hsa-miR-106b-5p | Breast carcinoma | MNDR-E-MI-03691 |
| MNDR | hsa-miR-106b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-03692 |
| MNDR | hsa-miR-106b-5p | Meningioma | MNDR-E-MI-03693 |
| MNDR | hsa-miR-106b-5p | Uterine cancer | MNDR-E-MI-03694 |
| MNDR | hsa-miR-106b-5p | Cervical adenocarcinoma | MNDR-E-MI-03695 |
| MNDR | hsa-miR-106b-5p | Gastric adenocarcinoma | MNDR-E-MI-03696 |
| MNDR | hsa-miR-106b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-03697 |
| MNDR | hsa-miR-106b-5p | Pituitary adenoma | MNDR-E-MI-03698 |
| MNDR | hsa-miR-106b-5p | Lung squamous cell carcinoma | MNDR-E-MI-03699 |
| MNDR | hsa-miR-106b-5p | Non-small cell lung cancer | MNDR-E-MI-03700 |
| MNDR | hsa-miR-106b-5p | Lung adenocarcinoma | MNDR-E-MI-03701 |
| MNDR | hsa-miR-106b-5p | Adrenocortical cancer | MNDR-E-MI-03702 |
| MNDR | hsa-miR-106b-5p | Thyroid carcinoma | MNDR-E-MI-03703 |
| MNDR | hsa-miR-106b-5p | Tuberculosis | MNDR-E-MI-03704 |
| MNDR | hsa-miR-106b-5p | Ovarian carcinoma | MNDR-E-MI-03705 |
| MNDR | hsa-miR-106b-5p | Bladder urothelial carcinoma | MNDR-E-MI-03706 |
| MNDR | hsa-miR-106b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-03707 |
| MNDR | hsa-miR-106b-5p | Liver disease | MNDR-E-MI-03708 |
| MNDR | hsa-miR-106b-5p | Brain stem cancer | MNDR-E-MI-03709 |
| MNDR | hsa-miR-106b-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-03710 |
| MNDR | hsa-miR-106b-5p | Carcinoma renal cell | MNDR-E-MI-03711 |
| MNDR | hsa-miR-106b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-03712 |
| MNDR | hsa-miR-106b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-03713 |
| MNDR | hsa-miR-106b-5p | Biliary tract cancer | MNDR-E-MI-03714 |
| MNDR | hsa-miR-106b-5p | Esophageal adenocarcinoma | MNDR-E-MI-03715 |
| MNDR | hsa-miR-106b-5p | Cholangiocarcinoma | MNDR-E-MI-03716 |
| MNDR | hsa-miR-106b-5p | Esophageal cancer | MNDR-E-MI-03717 |
| MNDR | hsa-miR-106b-5p | Lung small cell carcinoma | MNDR-E-MI-03718 |
| MNDR | hsa-miR-106b-5p | Encephalopathy bovine spongiform | MNDR-E-MI-03719 |
| MNDR | hsa-miR-106b-5p | Synovial sarcoma | MNDR-E-MI-03720 |
| MNDR | hsa-miR-106b-5p | Stomach carcinoma | MNDR-E-MI-03721 |
| MNDR | hsa-miR-106b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-03722 |
| MNDR | hsa-miR-106b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-03723 |
| MNDR | hsa-miR-106b-5p | Acute t cell leukemia | MNDR-E-MI-03724 |
| MNDR | hsa-miR-106b-5p | Heart failure | MNDR-E-MI-03725 |
| MNDR | hsa-miR-106b-5p | Breast invasive carcinoma | MNDR-E-MI-03726 |
| MNDR | hsa-miR-106b-5p | Hepatocellular carcinoma | MNDR-E-MI-03727 |
| MNDR | hsa-miR-106b-5p | Familiar ovarian carcinoma | MNDR-E-MI-03728 |
| MNDR | hsa-miR-106b-5p | B-cell lymphoma | MNDR-E-MI-03729 |
| MNDR | hsa-miR-106b-5p | Rheumatoid arthritis | MNDR-E-MI-03730 |
| MNDR | hsa-miR-106b-5p | T-cell leukemia | MNDR-E-MI-03731 |
| MNDR | hsa-miR-106b-5p | Retinoblastoma | MNDR-E-MI-03732 |
| MNDR | hsa-miR-106b-5p | Neuroblastoma | MNDR-E-MI-03733 |
| MNDR | hsa-miR-106b-5p | Hodgkin lymphoma | MNDR-E-MI-03734 |
| MNDR | hsa-miR-106b-5p | Burkitt lymphoma | MNDR-E-MI-03735 |
| MNDR | hsa-miR-106b-5p | Neuromyelitis optica | MNDR-E-MI-03736 |
| MNDR | hsa-miR-106b-5p | Psoriasis | MNDR-E-MI-03737 |
| MNDR | hsa-miR-106b-5p | Acute myelocytic leukemia | MNDR-E-MI-03738 |
| MNDR | hsa-miR-106b-5p | Colorectal cancer | MNDR-E-MI-03739 |
| MNDR | hsa-miR-106b-5p | Nasopharynx carcinoma | MNDR-E-MI-03740 |
| MNDR | hsa-miR-106b-5p | Multiple myeloma | MNDR-E-MI-03741 |
| MNDR | hsa-miR-106b-5p | Ependymoma | MNDR-E-MI-03742 |
| MNDR | hsa-miR-106b-5p | Nasopharyngeal cancer | MNDR-E-MI-03743 |
| MNDR | hsa-miR-106b-5p | Prostatic neoplasms | MNDR-E-MI-03744 |
| MNDR | hsa-miR-106b-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-03745 |
| MNDR | hsa-miR-106b-5p | Stroke lacunar | MNDR-E-MI-03746 |
| MNDR | hsa-miR-106b-5p | Breast cancer her3+ negative | MNDR-E-MI-03747 |
| MNDR | hsa-miR-106b-5p | Duke A | MNDR-E-MI-03748 |
| MNDR | hsa-miR-106b-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-03749 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022079 |
TOP